Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema
- PMID: 21057372
- PMCID: PMC3053443
- DOI: 10.1097/INF.0b013e3182002d14
Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema
Abstract
Background: Parapneumonic empyema (PPE) is an increasingly common complication of bacterial pneumonia. Epidemiologic study is complicated by the low frequency of positive cultures. We sought to describe the epidemiology of PPE in children using molecular analysis of pleural fluid.
Methods: We performed molecular testing for bacterial pathogens using archived pleural fluid from children hospitalized in 2009 with PPE. Real-time polymerase chain reaction (PCR) to detect Streptococcus pneumoniae, Staphylococcus aureus (including methicillin-resistant), Streptococcus pyogenes, Haemophilus influenzae, and Mycoplasma pneumoniae as well as PCR-based serotyping of S. pneumoniae was performed. Demographic, laboratory, and microbiologic data were abstracted.
Results: Pleural fluid specimens from 63 children were available for PCR. By culture, a pathogen was isolated from blood and/or pleural fluid in 22 (35%) patients, with S. pneumoniae in 15 (24%), S. pyogenes in 3 (5%), and methicillin-resistant Staphylococcus aureus in 4 (6%). By PCR, a pathogen was detected in 53 (84%), including S. pneumoniae in 45 (71%). Compared with culture, PCR testing significantly increased detection of any pathogen (35% vs. 84%; P < 0.001) and of S. pneumoniae (24% vs. 71%; P < 0.001). Serotype 7F was the most common pneumococcal serotype detected. Comparison of culture-negative to culture-positive disease showed differences in both the pathogen profile and clinical outcomes.
Conclusions: Molecular analysis of pleural fluid more than doubled the detection of pathogens causing PPE. S. pneumoniae was the most common cause of both culture-positive and culture-negative PPE, although serotype distribution and outcomes differed.
Conflict of interest statement
Similar articles
-
Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests.Respir Med. 2016 Jul;116:28-33. doi: 10.1016/j.rmed.2016.05.009. Epub 2016 May 10. Respir Med. 2016. PMID: 27296817 Free PMC article.
-
Changes in the incidence and bacterial aetiology of paediatric parapneumonic pleural effusions/empyema in Germany, 2010-2017: a nationwide surveillance study.Clin Microbiol Infect. 2019 Jul;25(7):857-864. doi: 10.1016/j.cmi.2018.10.020. Epub 2018 Nov 3. Clin Microbiol Infect. 2019. PMID: 30395932
-
Etiology of empyema thoracis and parapneumonic pleural effusion in Taiwanese children and adolescents younger than 18 years of age.Pediatr Infect Dis J. 2013 Apr;32(4):419-21. doi: 10.1097/INF.0b013e31828637b1. Pediatr Infect Dis J. 2013. PMID: 23340566
-
Broad-range bacterial polymerase chain reaction in the microbiologic diagnosis of complicated pneumonia.J Hosp Med. 2012 Jan;7(1):8-13. doi: 10.1002/jhm.911. Epub 2011 Oct 12. J Hosp Med. 2012. PMID: 21994146
-
Blood Culture and Pleural Fluid Culture Yields in Pediatric Empyema Patients: A Retrospective Review, 1996-2016.Pediatr Infect Dis J. 2018 Sep;37(9):952-954. doi: 10.1097/INF.0000000000001940. Pediatr Infect Dis J. 2018. PMID: 29438130 Review.
Cited by
-
Humoral immune responses to Streptococcus pneumoniae in the setting of HIV-1 infection.Vaccine. 2015 Aug 26;33(36):4430-6. doi: 10.1016/j.vaccine.2015.06.077. Epub 2015 Jun 30. Vaccine. 2015. PMID: 26141012 Free PMC article. Review.
-
Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Clinical and Hypoxemic Childhood Pneumonia over Three Years in Central Malawi: An Observational Study.PLoS One. 2017 Jan 4;12(1):e0168209. doi: 10.1371/journal.pone.0168209. eCollection 2017. PLoS One. 2017. PMID: 28052071 Free PMC article.
-
The changing epidemiology of invasive pneumococcal disease at a tertiary children's hospital through the 7-valent pneumococcal conjugate vaccine era: a case for continuous surveillance.Pediatr Infect Dis J. 2012 Mar;31(3):228-34. doi: 10.1097/INF.0b013e31823dcc72. Pediatr Infect Dis J. 2012. PMID: 22330164 Free PMC article.
-
Keep the old, in with the new: The changing face of pleural effusions.Afr J Thorac Crit Care Med. 2021 Dec 31;27(4):10.7196/AJTCCM.2021.v27i4.182. doi: 10.7196/AJTCCM.2021.v27i4.182. eCollection 2021. Afr J Thorac Crit Care Med. 2021. PMID: 35359694 Free PMC article. No abstract available.
-
The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.Clin Infect Dis. 2011 Oct;53(7):e25-76. doi: 10.1093/cid/cir531. Epub 2011 Aug 31. Clin Infect Dis. 2011. PMID: 21880587 Free PMC article.
References
-
- Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010;125:26–33. - PubMed
-
- Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1030–1032. - PubMed
-
- Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34:434–440. - PubMed
-
- Le Monnier A, Carbonnelle E, Zahar JR, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis. 2006;42:1135–1140. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical